Gregory A Marsh

VP, Transactions at Watermark Medical

Mr. Marsh has been working with Watermark in his current role and, prior to that, as a Company consultant since May 2016. Mr. Marsh’s primary responsibility has been coordinating recent transactional activity related to Watermark’s sale of numerous business segments in 2019. In addition, Mr. Marsh provides support and input around the Company’s ongoing initiatives and business development opportunities.

Mr. Marsh has over 35 years of financial and management experience, including CFO responsibilities for public and private companies and nine years of Public Accounting experience with Coopers and Lybrand. Mr. Marsh’s healthcare experience spans 25 years, with a primary emphasis on healthcare diagnostics companies. Before joining Watermark, Greg served as the CFO for Sentry Data Systems, Aurora Diagnostics, PDSHeart (CardioNet), and AmeriPath. Mr. Marsh has deep experience in mergers and acquisitions, having completed over 75 acquisitions and numerous successful exits for his companies. Mr. Marsh also has extensive experience in raising capital, including private equity, senior credit facilities, and both public equity and debt issuances.

Mr. Marsh holds a Bachelor of Science in Accounting from Slippery Rock State College. He is also a CPA and an active member of the FICPA and AICPA.

Timeline

  • VP, Transactions

    Current role

View in org chart